Effect of pyrrolidone-pyroglutamic acid composition on blood flow in rat middle cerebral artery

Bulletin of Experimental Biology and Medicine

Volumn 141, Issue 1, 2006, Pages 51-52

  Semkina, G A ^a   Matsievskii, D D ^a   Mirzoyan, N R ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

Cerebral blood flow; Middle cerebral artery; Nimodipine; Pyroglutamic acid; Pyrrolidone

Indexed keywords

2 PYRROLIDONE DERIVATIVE; NIMODIPINE; PYROGLUTAMIC ACID;

ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; RAT;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; DRUG COMBINATIONS; MALE; MIDDLE CEREBRAL ARTERY; NIMODIPINE; PYRROLIDINONES; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 33745090309     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0091-6     Document Type: Article

References (5)

1. E. V. Lun'shina, T. S. Gan'shina, and R. S. Mirzoyan, Eksp. Klin. Farmakol., 65, No. 3, 3-5 (2002).
2. D. D. Matsievskii, Byull. Eksp. Biol. Med., 136, No. 7, 115-118 (2003).
3. R. S. Mirzoyan, Eksp. Klin. Farmakol., 66, No. 2, 53-56 (2003).
4. R. S. Mirzoyan, G. A. Semkina, and D. D. Matsievskii, Byull. Eksp. Biol. Med., 118, No. 10, 410-413 (1994).
5. A. V. Topchyan, R. S. Mirzoyan, M. G. Balasanyan, et al., Eur. J. Pharm. Sci., 11, Suppl. 1, S117-S118 (2000).